Gossamer Bio(GOSS.US)

Last Updated 19:00:00 ET
longbridge loading

U.S. stock night trading volatility: Gossamer Bio rose 5.19% in after-hours trading, boosted by dual positive factors of debt restructuring and successful trials enhancing market confidence

Price Alert·
US
GOSS
-43.32%
Price Alert·
US
GOSS
-43.32%

GOSS 2-WEEK DEADLINE ALERT: Gossamer Bio Investors With Losses May Seek to Lead the Class Action After Executives Allegedly Concealed Placebo Risk: HBSS

PR Newswire·
US
GOSS
-43.32%
US
BBH
-1.03%
US
XBI
-2.31%
PR Newswire·
US
GOSS
-43.32%
US
BBH
-1.03%
US
XBI
-2.31%

Gossamer Bio Reports Q1 2026 Results: Full Earnings Call Transcript

benzinga_article·
US
GOSS
-43.32%
US
XBI
-2.31%
US
SBIO
-3.43%
benzinga_article·
US
GOSS
-43.32%
US
XBI
-2.31%
US
SBIO
-3.43%

Here are the major earnings after the close Monday

MSN·
US
GOSS
-43.32%
US
AGYS
+4.25%
US
MUFG
+1.86%
MSN·
US
GOSS
-43.32%
US
AGYS
+4.25%
US
MUFG
+1.86%

12 Health Care Stocks Moving In Monday's Pre-Market Session

benzinga_article·
US
GOSS
-43.32%
US
LTRN
-4.46%
US
AIM
+61.26%
benzinga_article·
US
GOSS
-43.32%
US
LTRN
-4.46%
US
AIM
+61.26%

Gossamer Bio Restructures Debt and Advances Seralutinib Program

Tip Ranks·
US
GOSS
-43.32%
US
SBIO
-3.43%
US
IHE
-0.44%
Tip Ranks·
US
GOSS
-43.32%
US
SBIO
-3.43%
US
IHE
-0.44%

Gossamer Bio Enters Noteholder Support Pact to Advance Convertible Notes Exchange

TradingView·
US
GOSS
-43.32%
TradingView·
US
GOSS
-43.32%
© 2026 Longbridge｜Disclaimer